United States · FDA National Drug Code directory
Eysuvis
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71571-333_db147c65-ed03-4af5-af1f-86b9ff51148a
- Product NDC
- 71571-333
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- loteprednol etabonate
- Labeler
- ALCON LABORATORIES, INC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201118
- Source listing expiry
- 20261231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (71571-333-01) / 1 mL in 1 BOTTLE, DROPPER · 71571-333-01
- 2.4 mL in 1 BOTTLE, DROPPER (71571-333-24) · 71571-333-24
- 1 BOTTLE, DROPPER in 1 CARTON (71571-333-83) / 8.3 mL in 1 BOTTLE, DROPPER · 71571-333-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →